Puma Biotechnology
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10880 Wilshire Blvd Ste 2150, Los Angele...Phone Number
(424) 248-6500Website
www.pumabiotechnology.comRevenue
$227.2 MillionStock Symbol
PBYIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Puma Biotechnology
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development of drug candidates in the clinical-testing phase. Puma Biotechnology specializes in the treatment of various forms of cancer. The company is headquartered in Los Angeles, California.Explore more
Puma Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Puma Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Puma Biotechnology is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Puma Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Click to see if Puma Biotechnology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Puma Biotechnology
Earning: See what the market has to say on Puma Biotechnology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Puma Biotechnology launches new products
Puma Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Puma Biotechnology has new funding data
Recommended Actions
Find VP level buyers at Puma Biotechnology
Find more new buyers
Compare Similar Companies to Puma Biotechnology
Compare insights from companies similar to Puma Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Puma Biotechnology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Puma Biotechnology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Puma Biotechnology.
Puma Biotechnology financials insights
Gather financial insights about Puma Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Share Placement
$55M
Share Placement
$60M
2012
Stock Offering
$129.1M
2014
Stock Offering
$129.3M
2015
Stock Offering
$205M
2016
Stock Offering
$162M
2017
Debt
$100M
Puma Biotechnology Tech Stack
A closer look at the technologies used by Puma Biotechnology
See more technologies
Most Recent Scoops
Hiring Plans
Puma Biotechnology has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Clinical Trials, Clinical Monitoring, Biotechnology, Patient Diary, Pharmaceuticals, and Clinical Trial Management Systems.
Hiring Plans
Person-Based
Marketing Campaign
Person-Based
Earnings, Financial Reporting, Finance
Person-Based
Share Placement, Finance
Person-Based
Earnings, Finance
Puma Biotechnology News & Media
Puma Biotechnology Q4 Earnings Call Highlights
Puma Biotechnology (NASDAQ:PBYI) reported fourth-quarter 2025 total revenue of $75.5 million, driven by NERLYNX product revenue and a sharp increase in royalty revenue, according to management’s comments on the company’s earnings call held February 26, 2026. Product revenue net, which management saPuma Biotechnology, Inc. Just Beat EPS By 278%: Here's What Analysts Think Will Happen Next
Puma Biotechnology, Inc. ( NASDAQ:PBYI ) just released its latest quarterly results and things are looking bullish. The...What Do Analysts Think About Puma Biotechnology (PBYI)?
Puma Biotechnology, Inc. (NASDAQ:PBYI) is one of the best affordable biotech stocks to invest in now. Puma Biotechnology, Inc. (NASDAQ:PBYI) reported its fiscal Q2 2025 results on August 7, with product revenue net for the quarter coming up to $49.2 million, up from $44.4 million in fiscal Q2 2024. The product revenue net consisted solely of […]Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT
Puma Biotechnology, Inc. (NASDAQ:PBYI) is one of the top most undervalued biotech stocks to buy now. In a report released on August 8, Gena Wang from Barclays maintained a Sell rating on Puma Biotechnology, Inc. (NASDAQ:PBYI) and set a price target of $2.00. The rating update came after Puma Biotechnology, Inc. (NASDAQ:PBYI) reported its fiscal […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Puma Biotechnology
Sign Up For FreeTo access detailed company insights
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development of drug candidates in the clinical-testing phase. Puma Biotechnology specializes in the treatment of various forms of cancer. The company is headquartered in Los Angeles, California.... Read More
